Marijuana M&A sizzled in 2021 and is poised for a hot 2022
Marijuana merger and acquisition activity proceeded at a torrid pace in 2021 - and could accelerate in 2022…
News December 28
Latest In: GW Pharma
GW Pharma expects fiscal 2020 sales to reach $526 million
United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec.…
News January 13
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement
Canadian cannabis producer Canopy Growth Corp. is suing Britain's GW Pharmaceuticals in U.S. federal court, alleging that GW…
News December 23
Sponsored
Green Life Business Group brokers the cannabis industry’s biggest deals
The best time to get into the cannabis industry is now.
June 22
Epidiolex maker GW Pharma reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales…
News November 4
GW Pharma trims loss to $8 million, warns virus could hit sales
GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but…
News May 12
Australia expedites review of medical cannabis product Epidiolex
The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another.
News January 30Featured
1
Latest Sponsored
